Detalhe da pesquisa
1.
CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours.
Nature
; 604(7906): 563-570, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35418687
2.
Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies.
Blood
; 2024 May 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38781564
3.
Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas.
Blood
; 132(14): 1495-1506, 2018 10 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30089630
4.
Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts.
Blood
; 127(2): 221-32, 2016 Jan 14.
Artigo
Inglês
| MEDLINE | ID: mdl-26463425
5.
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma.
Clin Cancer Res
; 30(9): 1859-1877, 2024 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38393682
6.
Anti-TACI single and dual-targeting CAR T cells overcome BCMA antigen loss in multiple myeloma.
Nat Commun
; 14(1): 7509, 2023 Nov 18.
Artigo
Inglês
| MEDLINE | ID: mdl-37980341
7.
Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma.
Neurooncol Adv
; 5(1): vdac185, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36751672
8.
EZH1 repression generates mature iPSC-derived CAR T cells with enhanced antitumor activity.
Cell Stem Cell
; 29(8): 1181-1196.e6, 2022 08 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35931029
9.
Non-cleavable hinge enhances avidity and expansion of CAR-T cells for acute myeloid leukemia.
Cancer Cell
; 40(5): 494-508.e5, 2022 05 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35452603
10.
Blockade or Deletion of IFNγ Reduces Macrophage Activation without Compromising CAR T-cell Function in Hematologic Malignancies.
Blood Cancer Discov
; 3(2): 136-153, 2022 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35015685
11.
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide.
Sci Transl Med
; 13(575)2021 01 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33408186
12.
Single-cell imaging of T cell immunotherapy responses in vivo.
J Exp Med
; 218(10)2021 10 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34415995
13.
Unraveling the Signaling Balance of Activation and Exhaustion of CAR T Cells.
Cancer Cell
; 37(2): 143-144, 2020 02 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32049043
14.
Publisher Correction: Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing.
Nat Biotechnol
; 38(7): 901, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-32541959
15.
Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources.
J Immunother Cancer
; 8(2)2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32900862
16.
CAR-Based Approaches to Cutaneous T-Cell Lymphoma.
Front Oncol
; 9: 259, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31058076
17.
Dynamic Profiling of Antitumor Activity of CAR T Cells Using Micropatterned Tumor Arrays.
Adv Sci (Weinh)
; 6(23): 1901829, 2019 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-31832320
18.
Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing.
Nat Biotechnol
; 37(3): 276-282, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30742127
19.
CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma.
J Immunother Cancer
; 7(1): 304, 2019 11 14.
Artigo
Inglês
| MEDLINE | ID: mdl-31727131
20.
Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma.
Blood Adv
; 3(21): 3248-3260, 2019 11 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31698455